Shopping Cart
- Remove All
- Your shopping cart is currently empty
NCGC00378430 is a potent SIX1/EYA2 interaction inhibitor that disrupts the [SIX1/EYA2] complex, EMT, and metastasis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 64 € | In Stock | |
5 mg | 154 € | In Stock | |
10 mg | 232 € | In Stock | |
25 mg | 439 € | In Stock | |
50 mg | 632 € | In Stock | |
100 mg | 881 € | In Stock | |
1 mL x 10 mM (in DMSO) | 170 € | In Stock |
Description | NCGC00378430 is a potent SIX1/EYA2 interaction inhibitor that disrupts the [SIX1/EYA2] complex, EMT, and metastasis. |
In vitro | NCGC00378430 reduces the SIX1/EYA2 interaction.?8430 partially reversed transcriptional and metabolic profiles mediated by SIX1 overexpression and reversed SIX1-induced TGFβ signaling and EMT. |
In vivo | NCGC00378430?was well tolerated when delivered to mice and significantly suppressed breast cancer associated metastasis in vivo without significantly altering primary tumor growth. |
Molecular Weight | 441.5 |
Formula | C22H23N3O5S |
Cas No. | 920650-00-6 |
Smiles | COc1ccc(NC(=O)c2cccc(c2)-n2cccc2)cc1S(=O)(=O)N1CCOCC1 |
Relative Density. | 1.34 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 90 mg/mL (203.85 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.